{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:13:55Z","timestamp":1791753235248,"version":"4.3.4"},"reference-count":46,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T00:00:00Z","timestamp":1126051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We analysed the impact of age and gender on biology and outcome of 2084 patients diagnosed with non\u2010Hodgkin lymphoma (NHL) between October 1986 and December 2002 and treated according to the Berlin\u2010Frankfurt\u2010M\u00fcnster (BFM) multicentre protocols NHL\u2010BFM\u201086, \u201090 and \u201095. Median age at diagnosis was 8\u00b70\u2003years for 97 precursor B\u2010lymphoblastic lymphoma (pB\u2010LBL) patients, 8\u00b78\u2003years for 335 T\u2010lymphoblastic lymphoma (T\u2010LBL) patients, 8\u00b74\u2003years for 1004 Burkitt's lymphoma\/leukaemia (BL\/B\u2010AL) patients, 11\u00b74\u2003years for 173 diffuse large B\u2010cell lymphoma (centroblastic subtype) (DLBCL\u2010CB) patients, 13\u00b72\u2003years for 40 primary mediastinal large B\u2010cell lymphoma (PMLBL) patients and 10\u00b78\u2003years for 215 anaplastic large\u2010cell lymphoma (ALCL) patients (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b700001). The male:female ratio was 0\u00b79:1 for pB\u2010LBL and PMLBL, 1\u00b77:1 for DLBCL\u2010CB, 1\u00b78:1 for ALCL, 2\u00b75:1 for T\u2010LBL and 4\u00b75:1 for BL\/B\u2010AL (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b700001). The probability of event\u2010free survival at 5 years (5\u2010year pEFS) was 85\u2003\u00b1\u20031% for all 2084 patients [median follow\u2010up 5\u00b77 (0\u00b71\u201315\u00b79) years], and was significantly superior for male T\u2010LBL and DLBCL\u2010CB patients. Comparing age\u2010groups 0\u20134, 5\u20139, 10\u201314 and 15\u201318\u2003years, pEFS was inferior for the youngest patients only in the pB\u2010LBL\u2010 and ALCL\u2010groups. T\u2010LBL and DLBCL\u2010CB adolescent females had worse outcome than younger girls while age had no impact on pEFS for boys. We conclude that the distribution of age and gender differed between NHL\u2010subtypes. The impact of gender on outcome differed between NHL subgroups. The prognostic impact of age differed not only by NHL\u2010subtype but also according to gender in some subtypes.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05735.x","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T08:20:52Z","timestamp":1126081252000},"page":"39-49","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":289,"title":["The impact of age and gender on biology, clinical features and treatment outcome of non\u2010Hodgkin lymphoma in childhood and adolescence"],"prefix":"10.1111","volume":"131","author":[{"given":"Birgit","family":"Burkhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilske","family":"Oschlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Niggli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Parwaresch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansjoerg","family":"Riehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the BFM Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,9,20]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1083"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0020332"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402595"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.4.1252"},{"key":"e_1_2_8_7_1","first-page":"3591","article-title":"CD30(+) anaplastic large\u2010cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology","volume":"92","author":"Brugieres L.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402402"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04134.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400959"},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox D.R.","year":"1972","journal-title":"Journal of the Royal Statistical Society"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2004.01.008"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06423.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1309\/8WYNVUTGV9RPHUQH"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176350951"},{"key":"e_1_2_8_16_1","volume-title":"WHO Classification, Tumours of Haematopoietic and Lymphoid Tissue","author":"Jaffe E.S.","year":"2001"},{"key":"e_1_2_8_17_1","volume-title":"German Childhood Cancer Registry, Annual Report 2003","author":"Kaatsch P.","year":"2004"},{"key":"e_1_2_8_18_1","first-page":"163","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleisch J.D.","year":"1980"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911113412007"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008372332584"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710303371802"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1630"},{"key":"e_1_2_8_24_1","first-page":"163","article-title":"Evaluation of survival data and tow new rank order statistics arising in its consideration","volume":"50","author":"Mantel E.","year":"1966","journal-title":"Cancer Chemotherapy Reports"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000139772.98685.d2"},{"key":"e_1_2_8_26_1","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non\u2010Hodgkin lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy S.B.","year":"1980","journal-title":"Seminars in Oncology"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3112"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200301000-00002"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950200204"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3370"},{"key":"e_1_2_8_31_1","first-page":"35","volume-title":"Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975\u20131995","author":"Percy C.L.","year":"1999"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20382"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.3.818"},{"key":"e_1_2_8_34_1","first-page":"4","article-title":"Prognostic factors in childhood T\u2010cell lymphoblastic lymphoma treated in the three consecutive NHL\u2010BFM studies (abstract)","volume":"25","author":"Pusill\u2010Wachtsmuth B.","year":"2003","journal-title":"Pediatric Hematology\/Oncology"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403253"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.5.899"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.359"},{"key":"e_1_2_8_38_1","first-page":"3294","article-title":"Improved treatment results in childhood B\u2010cell neoplasms with tailored intensification of therapy: a report of the Berlin\u2010Frankfurt\u2010Munster Group Trial NHL\u2010BFM 90","volume":"94","author":"Reiter A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_8_39_1","first-page":"416","article-title":"Intensive ALL\u2010type therapy without local radiotherapy provides a 90% event\u2010free survival for children with T\u2010cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605093341906"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950140311"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92623-4"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3699"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90367-4"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.6.1368"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03482.x"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0973"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05735.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05735.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T23:02:46Z","timestamp":1735945366000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05735.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,20]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05735.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05735.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,20]]},"assertion":[{"value":"2005-09-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}